IBDEI0VH ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15293,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15293,1,4,0)
 ;;=4^438.51
 ;;^UTILITY(U,$J,358.3,15293,1,5,0)
 ;;=5^CVA w/Oth Paralysis Dominant Side
 ;;^UTILITY(U,$J,358.3,15293,2)
 ;;=^317920
 ;;^UTILITY(U,$J,358.3,15294,0)
 ;;=438.52^^81^941^22
 ;;^UTILITY(U,$J,358.3,15294,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15294,1,4,0)
 ;;=4^438.52
 ;;^UTILITY(U,$J,358.3,15294,1,5,0)
 ;;=5^CVA w/Oth Paralysis Nondominant Side
 ;;^UTILITY(U,$J,358.3,15294,2)
 ;;=^317921
 ;;^UTILITY(U,$J,358.3,15295,0)
 ;;=438.53^^81^941^23
 ;;^UTILITY(U,$J,358.3,15295,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15295,1,4,0)
 ;;=4^438.53
 ;;^UTILITY(U,$J,358.3,15295,1,5,0)
 ;;=5^CVA w/Oth Paralysis,Bilateral
 ;;^UTILITY(U,$J,358.3,15295,2)
 ;;=^321176
 ;;^UTILITY(U,$J,358.3,15296,0)
 ;;=438.81^^81^941^4
 ;;^UTILITY(U,$J,358.3,15296,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15296,1,4,0)
 ;;=4^438.81
 ;;^UTILITY(U,$J,358.3,15296,1,5,0)
 ;;=5^CVA w/Apraxi NEC
 ;;^UTILITY(U,$J,358.3,15296,2)
 ;;=^317922
 ;;^UTILITY(U,$J,358.3,15297,0)
 ;;=438.83^^81^941^9
 ;;^UTILITY(U,$J,358.3,15297,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15297,1,4,0)
 ;;=4^438.83
 ;;^UTILITY(U,$J,358.3,15297,1,5,0)
 ;;=5^CVA w/Facial Weakness
 ;;^UTILITY(U,$J,358.3,15297,2)
 ;;=^328505
 ;;^UTILITY(U,$J,358.3,15298,0)
 ;;=438.85^^81^941^25
 ;;^UTILITY(U,$J,358.3,15298,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15298,1,4,0)
 ;;=4^438.85
 ;;^UTILITY(U,$J,358.3,15298,1,5,0)
 ;;=5^CVA w/Vertigo
 ;;^UTILITY(U,$J,358.3,15298,2)
 ;;=^328508
 ;;^UTILITY(U,$J,358.3,15299,0)
 ;;=438.21^^81^941^12
 ;;^UTILITY(U,$J,358.3,15299,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15299,1,4,0)
 ;;=4^438.21
 ;;^UTILITY(U,$J,358.3,15299,1,5,0)
 ;;=5^CVA w/Hemiplegia Dominant Side
 ;;^UTILITY(U,$J,358.3,15299,2)
 ;;=^317911
 ;;^UTILITY(U,$J,358.3,15300,0)
 ;;=438.22^^81^941^13
 ;;^UTILITY(U,$J,358.3,15300,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15300,1,4,0)
 ;;=4^438.22
 ;;^UTILITY(U,$J,358.3,15300,1,5,0)
 ;;=5^CVA w/Hemiplegia Nondominant Side
 ;;^UTILITY(U,$J,358.3,15300,2)
 ;;=^317912
 ;;^UTILITY(U,$J,358.3,15301,0)
 ;;=342.00^^81^941^38
 ;;^UTILITY(U,$J,358.3,15301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15301,1,4,0)
 ;;=4^342.00
 ;;^UTILITY(U,$J,358.3,15301,1,5,0)
 ;;=5^Flaccid Hemiplegia & Hemiparesis,Unspec Side
 ;;^UTILITY(U,$J,358.3,15301,2)
 ;;=^303258
 ;;^UTILITY(U,$J,358.3,15302,0)
 ;;=342.01^^81^941^36
 ;;^UTILITY(U,$J,358.3,15302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15302,1,4,0)
 ;;=4^342.01
 ;;^UTILITY(U,$J,358.3,15302,1,5,0)
 ;;=5^Flaccid Hemiplegia & Hemiparesis Dom
 ;;^UTILITY(U,$J,358.3,15302,2)
 ;;=^303259
 ;;^UTILITY(U,$J,358.3,15303,0)
 ;;=342.02^^81^941^37
 ;;^UTILITY(U,$J,358.3,15303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15303,1,4,0)
 ;;=4^342.02
 ;;^UTILITY(U,$J,358.3,15303,1,5,0)
 ;;=5^Flaccid Hemiplegia & Hemiparesis Nondom
 ;;^UTILITY(U,$J,358.3,15303,2)
 ;;=^303260
 ;;^UTILITY(U,$J,358.3,15304,0)
 ;;=342.80^^81^941^68
 ;;^UTILITY(U,$J,358.3,15304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15304,1,4,0)
 ;;=4^342.80
 ;;^UTILITY(U,$J,358.3,15304,1,5,0)
 ;;=5^Hemiplegia & Hemiparesis NEC,Unspec Side
 ;;^UTILITY(U,$J,358.3,15304,2)
 ;;=^303264
 ;;^UTILITY(U,$J,358.3,15305,0)
 ;;=342.81^^81^941^66
 ;;^UTILITY(U,$J,358.3,15305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15305,1,4,0)
 ;;=4^342.81
 ;;^UTILITY(U,$J,358.3,15305,1,5,0)
 ;;=5^Hemiplegia & Hemiparesis NEC Dom Side
 ;;^UTILITY(U,$J,358.3,15305,2)
 ;;=^303265
 ;;^UTILITY(U,$J,358.3,15306,0)
 ;;=342.82^^81^941^67
 ;;^UTILITY(U,$J,358.3,15306,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VH
